Pharmaceuticals

Plasma Therapy Market Forecast 2026–2030 Highlighting Expansion Across Industries

May 4, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Market Size Of The Plasma Therapy Market In 2026, And How Will Its Value Evolve By 2030?

The plasma therapy market has experienced swift expansion recently. Projections indicate its value will increase from $0.61 billion in 2025 to $0.69 billion by 2026, achieving a compound annual growth rate (CAGR) of 12.6%. Historically, this expansion was driven by several factors, including insufficient understanding of plasma therapy’s advantages, a preference for traditional medical approaches, the rising number of orthopedic and sports medicine interventions, an expansion in hospital and clinic facilities, and the initial integration of PRP in cosmetic applications.

The plasma therapy market is projected to experience swift expansion over the coming years. By 2030, its valuation is anticipated to reach $1.13 billion, exhibiting a compound annual growth rate (CAGR) of 13.0%. This projected growth stems from several factors, including the creation of advanced prp and prf formulations, increasing research in regenerative medicine, broadening applications of plasma therapy for chronic and cardiac injuries, greater acceptance in dermatology and dental care, and an increase in clinical trials and research institutes. Key developments anticipated during this period involve the rising uptake of platelet-rich plasma (prp) and platelet-rich fibrin (prf) treatments, wider use in regenerative medicine and orthopedic contexts, expanded application in dermatology, hair restoration, and plastic surgery, a growing need for injectable and membrane-based fibrin products, and the merging of research with clinical trials to improve therapeutic results.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3278&type=smp

What Factors Are Contributing To The Growth Of The Plasma Therapy Market?

The expanding incidence of osteoarthritis is projected to propel the plasma therapy market throughout the forecast period. Platelet-rich plasma (PRP), a variant of plasma therapy, is recognized as a safe and effective method for treating osteoarthritis. This concentrated autologous blood growth factor is administered directly into the joint to offer symptomatic relief by mitigating inflammation and decelerating the condition’s progression. For example, in September 2023, the Journal of Elsevier, a Netherlands-based publishing company, reported projections for osteoarthritis cases globally by 2050, indicating a rise of 74.9% (ranging from 59.4% to 89.9%) for the knee, 48.6% (ranging from 35.9% to 67.1%) for the hand, 78.6% (ranging from 57.7% to 105.3%) for the hip, and 95.1% (ranging from 68.1% to 135.0%) for other osteoarthritis types. Autologous chondrocyte implantation and scaffold implants are among the other widely utilized treatments for osteoarthritis. Hence, the increasing prevalence of osteoarthritis is set to drive the plasma therapy market.

Which Segment Categories Are Included In The Plasma Therapy Market Segment Analysis?

The plasma therapy market covered in this report is segmented –

1) By Type: Pure PRP, Leukocyte-rich PRP, Pure Platelet-rich Fibrin (PRF), Leukocyte-rich Fibrin (L-PRF)

2) By Application: Orthopedics, Arthritis, Chronic Tendinitis, Bone Repair & Regeneration, Dermatology, Androgenic Alopecia, Plastic Surgery, Dental, Cardiac Muscle Injury, Other Applications

3) By End-Users: Hospitals & Clinics, Laboratories: Research Institutes

Subsegments:

1) By Pure PRP: High Concentration PRP, Low Concentration PRP

2) By Leukocyte-Rich PRP: PRP With White Blood Cells, PRP With Growth Factors

3) By Pure Platelet-rich Fibrin (PRF): Injectable PRF, Membrane PRF

4) By Leukocyte-rich Fibrin (L-PRF): L-PRF Clots, L-PRF Membranes

What Trends Are Influencing The Plasma Therapy Market?

Leading companies active in the plasma therapy market are launching innovative products like the ESG-410 to address evolving patient needs and improve therapeutic choices. The ESG-410 functions as an Electrosurgical Generator, engineered to provide flexibility and effectiveness in the treatment of NMIBC (non-muscle-invasive bladder cancer) and benign prostatic hyperplasia. As an illustration, in June 2023, Olympus Corporation, a Japan-based medical technology firm, introduced its advanced electrosurgical generator, the ESG-410. This device is utilized for managing bladder cancer and an enlarged prostate. The ESG-410 incorporates sophisticated design features, such as improved capacitors, which ensure exceptional plasma stability during ignition. It boasts quick ignition and optimized plasma stability, marking an upgrade from the ESG-400, especially when deployed with various loop sizes and oval buttons. Furthermore, the ESG-410 Electrosurgical Generator offers enhanced treatment solutions for NMIBC and BPH by supplying a comprehensive selection of resection loops, electrodes, and vaporization instruments.

Who Are The Active Companies Shaping The Plasma Therapy Market?

Major companies operating in the plasma therapy market are Takeda Pharmaceutical Company Limited, Bio Products Laboratory Ltd., Arthrex Inc., Biotest AG, China Biologic Products Holdings Inc., DePuy Synthes Companies, CSL Limited, Grifols S.A., Octapharma AG, Terumo BCT Inc., Pfizer Inc., Kedrion Biopharma, ADMA Biologics Inc., SK Plasma Co. Ltd., Kamada Ltd., Fusion HealthCare, LFB Plasma, Baxter International Inc., Bayer AG, GC Biopharma Corp, Hualan Biological Engineering Inc., Japan Blood Products Organization, PlasmaCare Inc., ProMetic Life Sciences Inc., Sanquin, Shanghai RAAS Blood Products Co. Ltd., Canadian Plasma Resources, B Positive Plasma, Proesis Biologics Inc.

Get The Full Plasma Therapy Market Report:

https://www.thebusinessresearchcompany.com/report/plasmas-therapy-global-market-report

Where Is The Plasma Therapy Market Most Concentrated Geographically?

North America was the largest region in the plasma therapy market in 2025. The Middle East is expected to be the fastest-growing region in the global plasma therapy market share during the forecast period. The regions covered in the plasma therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Plasma Therapy Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/plasmas-therapy-global-market-report

Browse Through More Reports Similar to the Global Plasma Therapy Market 2026, By The Business Research Company

Apheresis Consumables And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/apheresis-consumables-and-equipment-global-market-report

Blood Transfusion Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

Hematology Analyzers And Reagents Market Report 2026

https://www.thebusinessresearchcompany.com/report/hematology-analyzers-and-reagents-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795